Perbedaan Diagnos Laboratorium Utama Tbk. dan Zyrexindo Mandiri Buana Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp222 (kapitalisasi pasar 308 M, volume 24 jam 129,6 rb), sedangkan Zyrexindo Mandiri Buana Tbk. diperdagangkan di Rp129 (kapitalisasi pasar 170,67 M, volume 24 jam 1,26 jt). Perbedaan utamanya: Diagnos Laboratorium Utama Tbk. lebih besar dari sisi kapitalisasi pasar, dan Zyrexindo Mandiri Buana Tbk. lebih aktif diperdagangkan (1,26 jt vs 129,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | ZYRX | |
|---|---|---|
Kapitalisasi Pasar | 308 M | 170,67 M |
Volume | 129,6 rb | 1,26 jt |
Lot | 1,3 rb | 12,6 rb |
Perputaran | 28,71 jt | 162,38 jt |
Harga Rata-rata | 221,54 | 128,9 |
Nilai Transaksi | 28,71 jt | 162,38 jt |
Harga Ekuilibrium Indikatif | 230 | 129 |
Volume Ekuilibrium Indikatif | 110 | 233 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Selengkapnya di halaman ZYRX →